Short-term expansion of breast circulating cancer cells predicts response to anti-cancer therapy

Circulating tumor cells (CTCs) are considered as surrogate markers for prognosticating and evaluating patient treatment responses. Here, 226 blood samples from 92 patients with breast cancer, including patients with newly diagnosed or metastatic refractory cancer, and 16 blood samples from healthy s...

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:Oncotarget
Hlavní autoři: Khoo, Bee Luan, Lee, Soo Chin, Kumar, Prashant, Tan, Tuan Zea, Warkiani, Majid Ebrahimi, Ow, Samuel GW., Nandi, Sayantani, Lim, Chwee Teck, Thiery, Jean Paul
Médium: Artigo
Jazyk:Inglês
Vydáno: Impact Journals LLC 2015
Témata:
Research Paper
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC4558172/
https://ncbi.nlm.nih.gov/pubmed/26008969
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky